Penserra Capital Management LLC Chinook Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.69 - $16.83 $10,957 - $17,250	-1,025 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.5 - $14.86 $115 - $148	10 Added 0.99%	1,025 $13,000
Q2 2021 Aug 12, 2021	BUY	$13.6 - $18.98 $748 - $1,043	55 Added 5.73%	1,015 $14,000
Q1 2021 May 13, 2021	SELL	$14.17 - $19.11 $70 - $95	-5 Reduced 0.52%	960 $14,000
Q4 2020 Feb 12, 2021	BUY	$11.9 - $20.91 $11,483 - $20,178	965 New	965 $15,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.